Genetic studies have shown that changes in the gene for APRIL are associated with an increased risk of developing IgA nephropathy. So what should clinicians know about the ARPIL pathway? Dive in with Dr. Jonathan Barratt, The Mayer Professor of Renal Medicine at the University of Leicester in the United Kingdom.